Profile: VAXIMM
Hum Vaccin Immunother
.
2013 Nov;9(11):2283-4.
doi: 10.4161/hv.26479.
Epub 2013 Sep 16.
Authors
Klaus Breiner
1
,
Heinz Lubenau
Affiliation
1
VAXIMM AG; Basel, Switzerland.
PMID:
24043272
DOI:
10.4161/hv.26479
No abstract available
Publication types
Interview
MeSH terms
Cancer Vaccines / immunology*
Cancer Vaccines / isolation & purification*
Humans
Immunotherapy / methods*
Neovascularization, Pathologic / prevention & control*
T-Lymphocytes / immunology*
Substances
Cancer Vaccines